Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,073 | -6,159 | -4,851 | -2,628 | -11,250 |
| Depreciation Amortization | 113 | 60 | 52 | 26 | 110 |
| Accounts receivable | -2 | 108 | 108 | -11 | N/A |
| Accounts payable and accrued liabilities | 40 | 382 | 41 | 20 | N/A |
| Other Working Capital | 701 | 1,554 | 571 | 415 | -290 |
| Other Operating Activity | 763 | -866 | -241 | 19 | 140 |
| Operating Cash Flow | $-8,458 | $-4,921 | $-4,320 | $-2,159 | $-11,290 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,889 | N/A | N/A | N/A | N/A |
| PPE Investments | 658 | 450 | 150 | N/A | 0 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 11,010 |
| Investing Cash Flow | $-6,231 | $450 | $150 | $N/A | $11,010 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,853 | 4,853 | N/A | N/A | N/A |
| Common Stock Issued | 26,514 | 23,975 | N/A | N/A | N/A |
| Other Financing Activity | -3 | -3 | 0 | 0 | -10 |
| Financing Cash Flow | $31,364 | $28,825 | $N/A | $N/A | $-10 |
| Beginning Cash Position | 7,726 | 7,726 | 7,726 | 7,726 | 8,020 |
| End Cash Position | 24,401 | 32,080 | 3,556 | 5,567 | 7,720 |
| Net Cash Flow | $16,675 | $24,354 | $-4,170 | $-2,159 | $-290 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,458 | -4,921 | -4,320 | -2,159 | -11,290 |
| Free Cash Flow | -8,458 | -4,921 | -4,320 | -2,159 | -11,290 |